Contact Us
- 800–CDC–INFO
- (800-232-4636)
- 888–232–6348 (TTY)
- cdcinfo@cdc.gov
Antiviral Agents for Seasonal Influenza: Information for Health Professionals
Although yearly vaccination with the flu vaccine is the primary strategy for preventing complications of influenza virus infections, antiviral medications with activity against influenza viruses can be effective for the prevention and treatment of influenza.
The links below provide information on CDC's recommendations for use of antiviral agents for seasonal influenza this flu season.
- Influenza Antiviral Medications: A Summary for Clinicians
Includes treatment, chemoprophylaxis, side effects, and dosing - Recommended Antiviral Agents for 2008-2009
Summary of the two antiviral agents approved for 2008-09: oseltamivir and zanamivir - ACIP: Indications for Use (Treatment and Prevention)
Guidelines on when antiviral treatment or prophylaxis are recommended - ACIP: Dosage
Guidelines for different groups, such as children, the elderly, and people with certain health conditions (includes a dosage table) - ACIP: Pharmacokinetics
Details on the drugs' interaction with the body - ACIP: Side Effects and Adverse Reactions
Description of the rare side effects of oseltamivir and zanamivir - ACIP: Antiviral Drug-Resistant Strains of Influenza Virus
Overview of the potential for resistance to oseltamivir and zanamivir - ACIP: Using Antiviral Medications to Control Influenza Outbreaks in Institutions
Description of the role of antiviral drugs in infection control
Related Links
- Antiviral Drugs and the Flu
Information for the general public - Questions & Answers: Antiviral Drugs for Seasonal Flu
Who should take antiviral medication, treatment benefits, side effects, and more - Patient information on oseltamivir (brand name Tamiflu®)
Provided by the U.S. Food and Drug Administration (FDA) - Consumer information on zanamivir (brand name Relenza®)
Provided by the U.S. Food and Drug Administration (FDA)
- Page last updated August 29, 2008
